Timothy P. Kelly

Insider Reports History

Location
Bedford, MA
Signature
/s/ Barbara G. McClung, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy P. Kelly:

Company Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Chief Operating Officer Employee Stock Option (Right to Buy) 28,200 $378,444 $13.42 24 Feb 2022 Direct
Caribou Biosciences, Inc. Chief Technology Officer Common Stock 37,500 $50,625 $1.35 20 Feb 2025 Direct
Homology Medicines, Inc. Chief Operating Officer Restricted Stock Units 4,800 $5,521 $1.15 24 Feb 2022 Direct
Homology Medicines, Inc. Chief Operating Officer Common Stock 2,224 $1,259 $0.5660 05 Jan 2022 Direct
Caribou Biosciences, Inc. Chief Technology Officer Option to purchase Common Stock 170,000 20 Feb 2025 Direct

Insider Reports Filed by Timothy P. Kelly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBU Caribou Biosciences, Inc. 20 Feb 2025 2 $0 4 Chief Technology Officer 21 Feb 2025, 20:18
CRBU Caribou Biosciences, Inc. 08 Jan 2024 1 $0 4 Chief Technology Officer 09 Jan 2024, 16:10
CRBU Caribou Biosciences, Inc. 01 Jan 2024 0 $0 3/A Chief Technology Officer 10 Jan 2024, 16:18
CRBU Caribou Biosciences, Inc. 01 Jan 2024 0 $0 3 Chief Technology Officer 09 Jan 2024, 16:07
QTTB Homology Medicines, Inc. 24 Feb 2022 2 $0 4 Chief Operating Officer 28 Feb 2022, 15:05
QTTB Homology Medicines, Inc. 01 Jan 2022 3 -$5,315 4 Chief Operating Officer 12 Jan 2022, 15:05
QTTB Homology Medicines, Inc. 03 Sep 2021 1 -$416 4 Chief Operating Officer 08 Sep 2021, 16:10
QTTB Homology Medicines, Inc. 01 Mar 2021 1 -$69,563 4/A Officer 08 Sep 2021, 16:05